Coronary age as a risk factor in the modified Framingham risk score

Enrique F Schisterman1, Brian W Whitcomb

  • 1Division of Epidemiology, Statistics and Prevention, National Institute of Child Health and Human Development, National Institute of Health, Department of Human Health Services, Bethesda, Maryland, USA. Schistee@mail.nih.gov

BMC Medical Imaging
|April 28, 2004
PubMed

Insights

A new method uses coronary calcium scores to create an "arterial age," improving the accuracy of the Framingham Risk Assessment for predicting coronary events. This approach offers more precise risk evaluation than chronological age alone.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Imaging

Background:

  • Clinical guidelines highlight risk assessment for patient selection in primary interventions.
  • Current risk assessment tools, like the Framingham Risk Score, have limitations in predicting future coronary events due to age variability.
  • Electron beam tomography (EBT) measures coronary calcium, offering a non-invasive assessment of plaque burden and potential

Purpose of the Study:

  • To introduce a novel method for modifying the Framingham Risk Assessment (FRA) by incorporating coronary calcium scores (CCS).
  • To generate a coronary artery calcium (CAC) age equivalent to replace chronological age in risk scoring.
  • To enhance the precision of cardiovascular risk prediction for individual patients.

Main Methods:

  • Developed a simple method to integrate CCS into the FRA.
  • Generated CAC age equivalents by matching individual CCS to age-group percentiles.
  • Replaced chronological age with CAC age equivalents within the Framingham scoring equations.

Main Results:

  • A 65-year-old man with a CCS of 6 had a 10-year risk of 10% using chronological age.
  • The modified risk score, using CAC age equivalents, reduced the 10-year risk to 2% for the same individual.
  • The method demonstrated potential to both increase and decrease predicted risk, indicating greater precision.

Conclusions:

  • Replacing chronological age with CAC age equivalents in the FRA offers a simple yet precise approach.
  • Physicians can derive adjusted Framingham risk scores for more accurate intervention decisions.
  • The modified FRA approach provides more precise cardiovascular risk estimates by utilizing coronary calcium information.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...